3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells.
Bioprinting
/ methods
Cell Adhesion
/ physiology
Cell Culture Techniques
/ methods
Cell Line, Tumor
Cell Survival
/ genetics
Chemokines
/ genetics
DNA Replication
/ genetics
Gene Expression
/ genetics
Humans
Hydrogels
/ chemistry
Leukemia, Lymphocytic, Chronic, B-Cell
/ genetics
Printing, Three-Dimensional
Tissue Scaffolds
/ chemistry
3D culture
B cell
bioprinting
chronic lymphocytic leukemia
leukemia
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
12
2020
accepted:
01
04
2021
entrez:
20
5
2021
pubmed:
21
5
2021
medline:
22
9
2021
Statut:
epublish
Résumé
Chronic Lymphocytic Leukemia (CLL) represents the most common leukemia in the western world and remains incurable. Leukemic cells organize and interact in the lymphoid tissues, however what actually occurs in these sites has not been fully elucidated yet. Studying primary CLL cells
Identifiants
pubmed: 34012434
doi: 10.3389/fimmu.2021.639572
pmc: PMC8126722
doi:
Substances chimiques
Chemokines
0
Hydrogels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
639572Informations de copyright
Copyright © 2021 Sbrana, Pinos, Barbaglio, Ribezzi, Scagnoli, Scarfò, Redwan, Martinez, Farè, Ghia and Scielzo.
Déclaration de conflit d'intérêts
Authors INR and HM were employed by CELLINK AB. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Crit Rev Oncol Hematol. 2016 Aug;104:169-82
pubmed: 27370174
Eur J Immunol. 2002 May;32(5):1403-13
pubmed: 11981828
Genome Biol. 2014;15(12):550
pubmed: 25516281
Behav Brain Res. 2001 Nov 1;125(1-2):279-84
pubmed: 11682119
Blood. 2016 Sep 22;128(12):1609-13
pubmed: 27480113
Blood. 2021 Mar 11;137(10):1365-1376
pubmed: 32992344
Nat Methods. 2008 Jul;5(7):621-8
pubmed: 18516045
Chem Soc Rev. 2013 Sep 7;42(17):7335-72
pubmed: 23609001
Haematologica. 2007 Mar;92(3):349-56
pubmed: 17339184
Adv Mater. 2004 Nov 30;16(21):1917-1921
pubmed: 25067887
Annu Rev Immunol. 1995;13:513-43
pubmed: 7612233
Semin Cancer Biol. 2014 Feb;24:43-8
pubmed: 23831274
Clin Immunol. 2013 Aug;148(2):279-86
pubmed: 23803409
Curr Opin Hematol. 2017 Jul;24(4):377-383
pubmed: 28426555
Blood. 2010 Nov 4;116(18):3537-46
pubmed: 20530793
Blood. 2020 May 21;135(21):1859-1869
pubmed: 32267500
Front Immunol. 2019 Feb 06;10:156
pubmed: 30787933
PLoS One. 2015 Oct 21;10(10):e0140506
pubmed: 26488876
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
J Biomater Sci Polym Ed. 2015;26(15):1002-12
pubmed: 26230911
Front Immunol. 2018 Sep 25;9:2159
pubmed: 30319622
Nature. 2003 Apr 17;422(6933):726-30
pubmed: 12692563
Front Oncol. 2020 Jan 31;10:67
pubmed: 32083012
Nat Methods. 2016 Apr 28;13(5):405-14
pubmed: 27123816
Leuk Lymphoma. 2020 Mar;61(3):510-524
pubmed: 31631728
Biomed Mater. 2016 Mar 04;11(2):022001
pubmed: 26942469
J Biomed Mater Res B Appl Biomater. 2012 Oct;100(7):1980-8
pubmed: 22888018
J Exp Med. 2019 May 6;216(5):1170-1181
pubmed: 30910796
Hematol Oncol. 2019 Jun;37 Suppl 1:38-42
pubmed: 31187520
Semin Oncol. 2016 Apr;43(2):222-32
pubmed: 27040700
Oncotarget. 2018 May 25;9(40):26019-26031
pubmed: 29899839
J Biol Chem. 2017 Feb 10;292(6):2510-2518
pubmed: 28011641
N Engl J Med. 2019 Aug 22;381(8):789
pubmed: 31433937
Graefes Arch Clin Exp Ophthalmol. 2019 Sep;257(9):1815-1822
pubmed: 30993457
Leuk Res. 1999 Feb;23(2):127-36
pubmed: 10071128
Assay Drug Dev Technol. 2014 May;12(4):207-18
pubmed: 24831787
Blood. 2008 Jun 15;111(12):5446-56
pubmed: 18216293
Haematologica. 2020 Jul 30;:
pubmed: 32732361
Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45
pubmed: 17684528
Cell Death Dis. 2020 Nov 2;11(11):941
pubmed: 33139702
Leukemia. 2017 Jun;31(6):1340-1347
pubmed: 28074063
Nat Commun. 2018 May 3;9(1):1787
pubmed: 29725010
Cancer J. 2019 Nov/Dec;25(6):378-385
pubmed: 31764118
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Br J Haematol. 1994 Oct;88(2):268-74
pubmed: 7803269
Int J Mol Sci. 2018 Feb 21;19(2):
pubmed: 29466296
J Biol Chem. 2003 Jan 3;278(1):37-47
pubmed: 12403782
Cancer Treat Rev. 2021 Mar;94:102154
pubmed: 33524794
Transl Oncol. 2021 Apr;14(4):101015
pubmed: 33493799
Haematologica. 2018 Mar;103(3):497-505
pubmed: 29242301
Front Oncol. 2020 Dec 17;10:607608
pubmed: 33392097
Bioact Mater. 2018 Feb 20;3(2):144-156
pubmed: 29744452
Oncotarget. 2011 Jun;2(6):448-60
pubmed: 21646687
Mol Med. 2011;17(11-12):1374-82
pubmed: 21968788
Front Oncol. 2020 Oct 08;10:592205
pubmed: 33134182
J Clin Epidemiol. 2014 Aug;67(8):850-7
pubmed: 24831050
Blood. 2009 Nov 26;114(23):4832-42
pubmed: 19789386